Albert David (BSE:524075) - Hisse Senedi Fiyatı, Haberler ve Analizler

524075 Stoklara Genel Bakış

Albert David Limited, Hindistan'da farmasötik formülasyonlar, infüzyon solüsyonları, bitkisel dozaj formları ve dökme ilaçlar üretmekte ve ticaretini yapmaktadır.

Şirket hakkında

524075 temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	4/6
Finansal Sağlık	5/6
Temettüler	5/6

Ödüller

Price-To-Earnings ratio (11.2x) is below the Indian market (33.3x)

Earnings grew by 22.2% over the past year

Pays a reliable dividend of 0.82%

Risk Analizi

Does not have a meaningful market cap (₹8B)

Albert David Limited Rakipler

Wanbury

BSE:524212

₹8.0b

Ind-Swift Laboratories

NSEI:INDSWFTLAB

₹7.1b

Nectar Lifesciences

NSEI:NECLIFE

₹8.7b

Sakar Healthcare

NSEI:SAKAR

₹6.8b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Albert David
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	₹1,394.20
52 Haftanın En Yüksek Seviyesi	₹1,752.95
52 Haftanın En Düşük Seviyesi	₹827.95
Beta	0.40
11 Aylık Değişim	-4.83%
3 Aylık Değişim	15.74%
1 Yıllık Değişim	63.32%
33 Yıllık Değişim	125.11%
5 Yıllık Değişim	248.64%
Halka arzdan bu yana değişim	9,787.94%

Son Haberler & Güncellemeler

Recent updates

Hissedar Getirileri

	524075	IN Pharmaceuticals	IN Pazar
7D	7.6%	2.0%	1.8%
1Y	63.3%	58.6%	36.8%

Getiri vs. Endüstri: 524075 exceeded the Indian Pharmaceuticals industry which returned 58.6% over the past year.

Getiri vs Piyasa: 524075 exceeded the Indian Market which returned 36.8% over the past year.

Fiyat Oynaklığı

Is 524075's price volatile compared to industry and market?
524075 volatility
524075 Average Weekly Movement	7.0%
Pharmaceuticals Industry Average Movement	6.3%
Market Average Movement	6.3%
10% most volatile stocks in IN Market	9.4%
10% least volatile stocks in IN Market	4.0%

İstikrarlı Hisse Senedi Fiyatı: 524075 has not had significant price volatility in the past 3 months compared to the Indian market.

Zaman İçindeki Volatilite: 524075's weekly volatility (7%) has been stable over the past year.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
1938	1,497	Umesh Kunte	www.albertdavidindia.com

Albert David Limited, Hindistan'da farmasötik formülasyonlar, infüzyon solüsyonları, bitkisel dozaj formları ve dökme ilaçlar üretmekte ve ticaretini yapmaktadır. Parenteral, oral/enteral, topikal ajanlar ve görme bakım ürünleri için formülasyonlar sunmaktadır. Şirket ürünlerini Latin Amerika, Güneydoğu Asya ve diğer Afrika ülkelerine ihraç etmektedir.

Albert David Limited Temel Bilgiler Özeti

Albert David'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
524075 temel i̇stati̇sti̇kler
Piyasa değeri	₹8.09b
Kazançlar(TTM)	₹707.73m
Gelir(TTM)	₹3.60b

11.2x

F/K Oranı

2.2x

P/S Oranı

524075 aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
524075 gelir tablosu (TTM)
Gelir	₹3.60b
Gelir Maliyeti	₹1.25b
Brüt Kâr	₹2.35b
Diğer Giderler	₹1.64b
Kazançlar	₹707.73m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	124.01
Brüt Marj	65.30%
Net Kâr Marjı	19.67%
Borç/Özkaynak Oranı	0.9%

524075 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

0.8%

Mevcut Temettü Verimi

9%

Ödeme Oranı

524075 Stoklara Genel Bakış

Ödüller

Risk Analizi

Albert David Limited Rakipler

BSE:524212

₹8.0b

NSEI:INDSWFTLAB

₹7.1b

NSEI:NECLIFE

₹8.7b

NSEI:SAKAR

₹6.8b

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Now 24% overvalued after recent price rise

Investor sentiment improves as stock rises 24%

Albert David Limited Approves Dividend for the Financial Year Ended on March 31, 2024

Now 20% overvalued after recent price rise

Upcoming dividend of ₹11.50 per share

Full year 2024 earnings released: EPS: ₹132 (vs ₹63.39 in FY 2023)

Recent updates

Now 24% overvalued after recent price rise

Investor sentiment improves as stock rises 24%

Albert David Limited Approves Dividend for the Financial Year Ended on March 31, 2024

Now 20% overvalued after recent price rise

Upcoming dividend of ₹11.50 per share

Full year 2024 earnings released: EPS: ₹132 (vs ₹63.39 in FY 2023)

Now 23% overvalued after recent price rise

Now 21% overvalued after recent price rise

Investor sentiment improves as stock rises 19%

Dividend of ₹11.50 announced

Albert David Limited, Annual General Meeting, Aug 09, 2024

Full year 2024 earnings released: EPS: ₹132 (vs ₹63.39 in FY 2023)

Albert David Limited to Report Q4, 2024 Results on May 13, 2024

Albert David Limited Announces Resignation of Abhishek Seth as Company Secretary & Compliance Officer, Effective May 31, 2024

New minor risk - Share price stability

Albert David Limited Announces Management Changes

Third quarter 2024 earnings released: EPS: ₹32.80 (vs ₹18.48 in 3Q 2023)

Albert David Limited to Report Q3, 2024 Results on Feb 05, 2024

Investor sentiment improves as stock rises 16%

Albert David Limited Announces Resignation of A. B. Chakrabartty as Company Secretary and Compliance Officer Cum Legal Head of the Company

Second quarter 2024 earnings released: EPS: ₹35.57 (vs ₹35.29 in 2Q 2023)

Albert David Limited Approves Dividend for the Financial Year Ended March 31, 2023

First quarter 2024 earnings released: EPS: ₹41.16 (vs ₹3.08 in 1Q 2023)

Albert David Limited to Report Q1, 2024 Results on Aug 10, 2023

Upcoming dividend of ₹9.00 per share at 1.3% yield

Full year 2023 earnings released: EPS: ₹63.39 (vs ₹61.78 in FY 2022)

Albert David Limited, Annual General Meeting, Aug 10, 2023

Albert David Limited to Report Q4, 2023 Results on May 19, 2023

Third quarter 2023 earnings released: EPS: ₹18.48 (vs ₹13.96 in 3Q 2022)

Albert David Limited to Report Q3, 2023 Results on Feb 13, 2023

Albert David Limited Appoints Mr. A B Chakrabartty as the Company Secretary & Compliance Officer Cum Legal Head of the Company

Second quarter 2023 earnings released: EPS: ₹35.29 (vs ₹22.20 in 2Q 2022)

Albert David Limited to Report Q2, 2023 Results on Nov 12, 2022

Albert David Limited Announces Reconstitution of Committees of the Board of Directors

Albert David Limited Announces Resignation of Tarminder Singh Parmar as Managing Director and CEO, Effective December 8, 2022

Albert David Limited Announces Management Changes

Upcoming dividend of ₹9.00 per share

Full year 2022 earnings released

Albert David Limited, Annual General Meeting, Aug 09, 2022

Executive Chairman recently bought ₹1.1m worth of stock

Albert David Limited Approves the Appointment of Anand Vardhan Kothari as an Additional Director (Non-Executive Non-Independent)

Full year 2022 earnings released: EPS: ₹61.78 (vs ₹38.80 in FY 2021)

Albert David Limited Recommends Dividend for the Financial Year Ended 31 March, 2022

Insufficient new directors

Executive Chairman recently bought ₹536k worth of stock

Insufficient new directors

Executive Chairman recently bought ₹1.6m worth of stock

Insufficient new directors

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS ₹22.20 (vs ₹17.16 in 2Q 2021)

Upcoming dividend of ₹6.00 per share

First quarter 2022 earnings released: EPS ₹18.30 (vs ₹7.65 in 1Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹38.80 (vs ₹33.59 in FY 2020)

Insider recently bought ₹189k worth of stock

Executive Chairman recently bought ₹199k worth of stock

New 90-day low: ₹399

Third quarter 2021 earnings released: EPS ₹10.72 (vs ₹9.20 in 3Q 2020)